Research LibrarySourcing GuidesWhere to Buy Retatrutide
Sourcing Guide · 2026

Where to Buy Retatrutide
Research-Grade Sourcing Guide (2026)

Retatrutide is the most structurally complex incretin peptide currently available in the research market — a triple GLP-1/GIP/glucagon receptor agonist under active Phase 3 investigation by Eli Lilly. It is also the hardest to synthesize correctly, with wider quality variance than any comparable peptide.

GLP-1 AgonistGIP AgonistGlucagon AgonistTriple AgonistUpdated June 2026

At a Glance

Purity Standard
≥98% HPLC + MS
Receptor Targets
GLP-1R + GIPR + GcgR
MW
~4,762 Da
Quality Price Range
$120–$170 / 10mg
Helixera Price
from $134.95 / 5mg
Clinical Status
Phase 3 (TRIUMPH)

Helixera Labs Retatrutide — from $134.95

Third-party tested · Batch-specific COA · Same or next business day · US-based · For research use only

Order Retatrutide →

1. Regulatory and clinical status in 2026

Retatrutide (LY3437943) is an investigational compound developed by Eli Lilly currently in Phase 3 clinical trials (TRIUMPH program). As of June 2026 it is not FDA-approved and is not available through pharmacies or compounding channels.

ℹ️

Key distinction: Unlike tirzepatide, retatrutide has no approved pharmaceutical equivalent in 2026. The only legal access route outside of clinical trial enrollment is research-grade procurement from compliant vendors — for in vitro laboratory research use only.

⚠️

Research use only. Retatrutide sold by Helixera Labs is for laboratory research use only. Not approved for human or veterinary use.

2. Synthesis complexity and quality variance

🧬

Triple Receptor Architecture

Simultaneous GLP-1R, GIPR, and glucagon receptor agonism requires precise structural features at multiple receptor interaction sites.

⛓️

C18 Fatty Diacid Modification

More complex than tirzepatide's C20 fatty acid. Incorrect conjugation produces a compound with different pharmacological properties.

🔬

Novel Compound

Fewer vendors have established reliable synthesis pipelines and less independent third-party testing data exists to benchmark against.

📊

Widest Price Spread

The per-mg price spread for retatrutide is among the widest of any research peptide — vendors pricing below market are almost invariably cutting corners.

3. Vendor evaluation criteria

Research-Grade Retatrutide — Vendor Checklist

  • HPLC purity ≥98% from an independent laboratory
  • Mass spectrometry confirming correct molecular weight (~4,762 Da)
  • C18 fatty diacid conjugation confirmation via MS
  • Batch-specific COA with lot number matching the vial
  • Cold-pack shipping as standard
  • Lyophilized powder format only
  • US-based operation with verifiable business identity
  • No therapeutic claims anywhere on the vendor site
🚫

Red flags: HPLC only with no MS · Generic COA · Pre-mixed formats · Pricing significantly below quality range · Therapeutic claims · No verifiable US contact

4. COA requirements

Retatrutide COA Checklist

  • Lot number matching the vial — batch-specific, not generic
  • HPLC purity with raw chromatogram available on request
  • Mass spectrometry confirming molecular weight (~4,762 Da)
  • Sequence identity confirmation
  • C18 fatty diacid conjugation confirmation
  • Actual weight per vial vs. label claim
  • Independent laboratory name — verifiable third party
  • Testing date within 90 days of production

5. 2026 pricing overview

Format Quality vendor range Budget range Per-mg (quality)
5mg vial $90–$130 $45–$70 ~$18–$26/mg
10mg vial $120–$170 $60–$100 ~$12–$17/mg
30mg vial $200–$280 $90–$150 ~$6–$9/mg

6. Helixera Labs Retatrutide

Helixera Labs — RetatrutideIn Stock

Retatrutide — Research Grade

Triple GLP-1/GIP/Glucagon Receptor Agonist · Lyophilized Powder · For research use only

  • ≥98% purity — third-party HPLC and MS tested
  • Mass spectrometry identity and conjugation confirmation
  • Batch-specific COA available on request
  • Same or next business day fulfillment from Ukiah, California
  • Free 2-day shipping on orders $150+
  • Discreet plain packaging · US-based — Helixera Labs LLC
  • Phone and text support: 1-866-463-0683

7. Research context and related compounds

Compound Receptor Targets Research Status
Semaglutide GLP-1R FDA approved / research grade available
Tirzepatide GLP-1R + GIPR FDA approved / research grade available
Retatrutide GLP-1R + GIPR + GcgR Phase 3 investigational / research grade available
Cagrilintide Amylin receptor Phase 3 investigational / research grade available

For detailed mechanism of action and published research literature, see the Retatrutide Research Overview.

FAQ

Is retatrutide available through pharmacies or compounding in 2026?
+
No. Unlike tirzepatide and semaglutide, retatrutide has no approved pharmaceutical equivalent as of June 2026. Access routes are clinical trial enrollment (Eli Lilly's TRIUMPH program) or research-grade procurement for laboratory research use only.
Is it legal to purchase research-grade retatrutide in 2026?
+
Yes, for legitimate in vitro laboratory research. Retatrutide is not a scheduled controlled substance and is legal to purchase as a research chemical.
Why is retatrutide harder to source than tirzepatide?
+
Three reasons: triple receptor architecture requires precise structural features at multiple binding sites; the C18 fatty diacid modification is more complex to conjugate; and the compound is newer in the research market with fewer vendors having established reliable synthesis pipelines.
How do I request a COA from Helixera?
+
Contact us at helixerapeptides.com/pages/contact or call 1-866-463-0683 with your order number.

Order Retatrutide from Helixera Labs

≥98% purity · MS verified · Batch COA · Same or next business day · For research use only

Order Now →

All compounds listed are for laboratory research use only. Not for human or veterinary use. © 2026 Helixera Labs LLC · Terms · Privacy